27 results on '"Hedrich, Ulrike B. S."'
Search Results
2. KCNC2 variants of uncertain significance are also associated to various forms of epilepsy.
- Author
-
Seiffert, Simone, Pendziwiat, Manuela, Hedrich, Ulrike B. S., Helbig, Ingo, Weber, Yvonne, and Schwarz, Niklas
- Subjects
EPILEPSY ,POTASSIUM channels ,XENOPUS laevis ,VALPROIC acid ,CHANNEL coding - Abstract
Recently, de novo variants in KCNC2, coding for the potassium channel subunit KV3.2, have been described as causative for various forms of epilepsy including genetic generalized epilepsy (GGE) and developmental and epileptic encephalopathy (DEE). Here, we report the functional characteristics of three additional KCNC2 variants of uncertain significance and one variant classified as pathogenic. Electrophysiological studies were performed in Xenopus laevis oocytes. The data presented here support that KCNC2 variants with uncertain significance may also be causative for various forms of epilepsy, as they show changes in the current amplitude and activation and deactivation kinetics of the channel, depending on the variant. In addition, we investigated the effect of valproic acid on KV3.2, as several patients carrying pathogenic variants in the KCNC2 gene achieved significant seizure reduction or seizure freedom with this drug. However, in our electrophysiological investigations, no change on the behavior of KV3.2 channels could be observed, suggesting that the therapeutic effect of VPA may be explained by other mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Loss or gain of function? Effects of ion channel mutations on neuronal firing depend on the neuron type.
- Author
-
Koch, Nils A., Sonnenberg, Lukas, Hedrich, Ulrike B. S., Lauxmann, Stephan, and Benda, Jan
- Subjects
ACTION potentials ,ION channels ,VOLTAGE-gated ion channels ,SPINOCEREBELLAR ataxia ,INDIVIDUALIZED medicine - Abstract
Introduction: Clinically relevant mutations to voltage-gated ion channels, called channelopathies, alter ion channel function, properties of ionic currents, and neuronal firing. The effects of ion channel mutations are routinely assessed and characterized as loss of function (LOF) or gain of function (GOF) at the level of ionic currents. However, emerging personalized medicine approaches based on LOF/GOF characterization have limited therapeutic success. Potential reasons are among others that the translation from this binary characterization to neuronal firing is currently not well-understood--especially when considering different neuronal cell types. In this study, we investigate the impact of neuronal cell type on the firing outcome of ion channel mutations. Methods: To this end, we simulated a diverse collection of single-compartment, conductance-based neuron models that differed in their composition of ionic currents. We systematically analyzed the effects of changes in ion current properties on firing in different neuronal types. Additionally, we simulated the effects of knownmutations in KCNA1 gene encoding the KV1.1 potassiumchannel subtype associated with episodic ataxia type 1 (EA1). Results: These simulations revealed that the outcome of a given change in ion channel properties on neuronal excitability depends on neuron type, i.e., the properties and expression levels of the unaffected ionic currents. Discussion: Consequently, neuron-type specific effects are vital to a full understanding of the effects of channelopathies on neuronal excitability and are an important step toward improving the efficacy and precision of personalized medicine approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. In vitro effects of eslicarbazepine (S‐licarbazepine) as a potential precision therapy on SCN8A variants causing neuropsychiatric disorders.
- Author
-
Bayraktar, Erva, Liu, Yuanyuan, Sonnenberg, Lukas, Hedrich, Ulrike B. S., Sara, Yildirim, Eltokhi, Ahmed, Lyu, Hang, Lerche, Holger, Wuttke, Thomas V., and Lauxmann, Stephan
- Subjects
SODIUM channels ,NEUROBEHAVIORAL disorders ,EPILEPSY ,CHANNEL coding ,BRAIN diseases ,GENETIC code - Abstract
Background and Purpose: Variants in SCN8A, the NaV1.6 channel's coding gene, are characterized by a variety of symptoms, including intractable epileptic seizures, psychomotor delay, progressive cognitive decline, autistic features, ataxia or dystonia. Standard anticonvulsant treatment has a limited impact on the course of disease. Experimental Approach: We investigated the therapeutic potential of eslicarbazepine (S‐licarbazepine; S‐lic), an enhancer of slow inactivation of voltage gated sodium channels, on two variants with biophysical and neuronal gain‐of‐function (G1475R and M1760I) and one variant with biophysical gain‐of‐function but neuronal loss‐of‐function (A1622D) in neuroblastoma cells and in murine primary hippocampal neuron cultures. These three variants cover the broad spectrum of NaV1.6‐associated disease and are linked to representative phenotypes of mild to moderate epilepsy (G1475R), developmental and epileptic encephalopathy (M1760I) and intellectual disability without epilepsy (A1622D). Key Results: Similar to known effects on NaV1.6 wildtype channels, S‐lic predominantly enhances slow inactivation on all tested variants, irrespective of their particular biophysical mechanisms. Beyond that, S‐lic exhibits variant‐specific effects including a partial reversal of pathologically slowed fast inactivation dynamics (A1622D and M1760I) and a trend to reduce enhanced persistent Na+ current by A1622D variant channels. Furthermore, our data in primary transfected neurons reveal that not only variant‐associated hyperexcitability (M1760I and G1475R) but also hypoexcitability (A1622D) can be modulated by S‐lic. Conclusions and Implications: S‐lic has not only substance‐specific effects but also variant‐specific effects. Personalized treatment regimens optimized to achieve such variant‐specific pharmacological modulation may help to reduce adverse side effects and improve the overall therapeutic outcome of SCN8A‐related disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. KCNA1 gain‐of‐function epileptic encephalopathy treated with 4‐aminopyridine.
- Author
-
Müller, Peter, Takacs, Danielle S., Hedrich, Ulrike B. S., Coorg, Rohini, Masters, Laura, Glinton, Kevin E., Dai, Hongzheng, Cokley, Jon A., Riviello, James J., Lerche, Holger, and Cooper, Edward C.
- Subjects
BRAIN diseases ,PEOPLE with epilepsy ,INDIVIDUALIZED medicine ,EPILEPSY ,PATIENT readmissions - Abstract
Precision medicine for Mendelian epilepsy is rapidly developing. We describe an early infant with severely pharmacoresistant multifocal epilepsy. Exome sequencing revealed the de novo variant p.(Leu296Phe) in the gene KCNA1, encoding the voltage‐gated K+ channel subunit KV1.1. So far, loss‐of‐function variants in KCNA1 have been associated with episodic ataxia type 1 or epilepsy. Functional studies of the mutated subunit in oocytes revealed a gain‐of‐function caused by a hyperpolarizing shift of voltage dependence. Leu296Phe channels are sensitive to block by 4‐aminopyridine. Clinical use of 4‐aminopyridine was associated with reduced seizure burden, enabled simplification of co‐medication and prevented rehospitalization. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Pathophysiologische Mechanismen genetischer Epilepsien
- Author
-
Hedrich, Ulrike B. S. and Maljevic, Snezana
- Published
- 2016
- Full Text
- View/download PDF
7. Predicting functional effects of ion channel variants using new phenotypic machine learning methods.
- Author
-
Boßelmann, Christian Malte, Hedrich, Ulrike B. S., Lerche, Holger, and Pfeifer, Nico
- Subjects
- *
VOLTAGE-gated ion channels , *ION channels , *MACHINE learning , *SUPERVISED learning , *HUMAN phenotype , *PHENOTYPES , *AMINO acid sequence - Abstract
Missense variants in genes encoding ion channels are associated with a spectrum of severe diseases. Variant effects on biophysical function correlate with clinical features and can be categorized as gain- or loss-of-function. This information enables a timely diagnosis, facilitates precision therapy, and guides prognosis. Functional characterization presents a bottleneck in translational medicine. Machine learning models may be able to rapidly generate supporting evidence by predicting variant functional effects. Here, we describe a multi-task multi-kernel learning framework capable of harmonizing functional results and structural information with clinical phenotypes. This novel approach extends the human phenotype ontology towards kernel-based supervised machine learning. Our gain- or loss-of-function classifier achieves high performance (mean accuracy 0.853 SD 0.016, mean AU-ROC 0.912 SD 0.025), outperforming both conventional baseline and state-of-the-art methods. Performance is robust across different phenotypic similarity measures and largely insensitive to phenotypic noise or sparsity. Localized multi-kernel learning offered biological insight and interpretability by highlighting channels with implicit genotype-phenotype correlations or latent task similarity for downstream analysis. Author summary: Genetic variants can impact the function of voltage-gated ion channels, which are transmembrane channels that are important for the electrical signalling of neurons. Individuals affected by these variants may have severe neurological or cardiac disease. Knowing the functional effects of variants can help us improve the diagnosis and clinical care for these individuals, and may also enable precision medicine aimed at correcting channel function. Machine learning methods are capable of predicting these functional effects, but previous models have only included information from protein sequence and structure. Here, we have developed a novel algorithm that can integrate clinical information by using the Human Phenotype Ontology (HPO), a standardized vocabulary of phenotypic features encountered in human disease. These different sources of information are used to train a multi-kernel support-vector machine. Our results suggest that this model is robust, interpretable, and more accurate than previous methods. Variant functional effect prediction engines will be useful tools for clinical geneticists, neurologists and biophysicists. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. An SCN2A mutation in a family with infantile seizures from Madagascar reveals an increased subthreshold Na+ current
- Author
-
Lauxmann, Stephan, Boutry-Kryza, Nadia, Rivier, Clotilde, Mueller, Stephan, Hedrich, Ulrike B. S., Maljevic, Snezana, Szepetowski, Pierre, Lerche, Holger, and Lesca, Gaetan
- Published
- 2013
- Full Text
- View/download PDF
9. KCND2 variants associated with global developmental delay differentially impair Kv4.2 channel gating.
- Author
-
Zhang, Yongqiang, Tachtsidis, Georgios, Schob, Claudia, Koko, Mahmoud, Hedrich, Ulrike B S, Lerche, Holger, Lemke, Johannes R, Haeringen, Arie van, Ruivenkamp, Claudia, Prescott, Trine, Tveten, Kristian, Gerstner, Thorsten, Pruniski, Brianna, DiTroia, Stephanie, VanNoy, Grace E, Rehm, Heidi L, McLaughlin, Heather, Bolz, Hanno J, Zechner, Ulrich, and Bryant, Emily
- Published
- 2021
- Full Text
- View/download PDF
10. Hyperexcitable interneurons trigger cortical spreading depression in an Scn1a migraine model.
- Author
-
Auffenberg, Eva, Hedrich, Ulrike B. S., Barbieri, Raffaella, Miely, Daniela, Groschup, Bernhard, Wuttke, Thomas V., Vogel, Niklas, Lührs, Philipp, Zanardi, Ilaria, Bertelli, Sara, Spielmann, Nadine, Gailus-Durner, Valerie, Fuchs, Helmut, de Angelis, Martin Hrabě, Pusch, Michael, Dichgans, Martin, Lerche, Holger, Gavazzo, Paola, Plesnila, Nikolaus, and Freilinger, Tobias
- Abstract
Cortical spreading depression (CSD), a wave of depolarization followed by depression of cortical activity, is a pathophysiological process implicated in migraine with aura and various other brain pathologies, such as ischemic stroke and traumatic brain injury. To gain insight into the pathophysiology of CSD, we generated a mouse model for a severe monogenic subtype of migraine with aura, familial hemiplegic migraine type 3 (FHM3). FHM3 is caused by mutations in SCN1A, encoding the voltage-gated Na+ channel NaV1.1 predominantly expressed in inhibitory interneurons. Homozygous Scn1aL1649Q knock-in mice died prematurely, whereas heterozygous mice had a normal lifespan. Heterozygous Scn1aL1649Q knock-in mice compared with WT mice displayed a significantly enhanced susceptibility to CSD. We found L1649Q to cause a gain-of-function effect with an impaired Na+ -channel inactivation and increased ramp Na+ currents leading to hyperactivity of fast-spiking inhibitory interneurons. Brain slice recordings using K+ -sensitive electrodes revealed an increase in extracellular K+ in the early phase of CSD in heterozygous mice, likely representing the mechanistic link between interneuron hyperactivity and CSD initiation. The neuronal phenotype and premature death of homozygous Scn1aL1649Q knock-in mice was partially rescued by GS967, a blocker of persistent Na+ currents. Collectively, our findings identify interneuron hyperactivity as a mechanism to trigger CSD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Dravet Variant SCN1A A 1783 V Impairs Interneuron Firing Predominantly by Altered Channel Activation.
- Author
-
Layer, Nikolas, Sonnenberg, Lukas, Pardo González, Emilio, Benda, Jan, Hedrich, Ulrike B. S., Lerche, Holger, Koch, Henner, and Wuttke, Thomas V.
- Subjects
MISSENSE mutation ,SODIUM channels ,LABORATORY mice ,GENETIC variation ,INTERNEURONS ,PYRAMIDAL neurons ,BRAIN diseases ,ANIMAL disease models - Abstract
Dravet syndrome (DS) is a developmental epileptic encephalopathy mainly caused by functional Na
V 1.1 haploinsufficiency in inhibitory interneurons. Recently, a new conditional mouse model expressing the recurrent human p.(Ala1783Val) missense variant has become available. In this study, we provided an electrophysiological characterization of this variant in tsA201 cells, revealing both altered voltage-dependence of activation and slow inactivation without reduced sodium peak current density. Based on these data, simulated interneuron (IN) firing properties in a conductance-based single-compartment model suggested surprisingly similar firing deficits for NaV 1.1A1783V and full haploinsufficiency as caused by heterozygous truncation variants. Impaired NaV 1.1A1783V channel activation was predicted to have a significantly larger impact on channel function than altered slow inactivation and is therefore proposed as the main mechanism underlying IN dysfunction. The computational model was validated in cortical organotypic slice cultures derived from conditional Scn1aA 1783 V mice. Pan-neuronal activation of the p.Ala1783V in vitro confirmed a predicted IN firing deficit and revealed an accompanying reduction of interneuronal input resistance while demonstrating normal excitability of pyramidal neurons. Altered input resistance was fed back into the model for further refinement. Taken together these data demonstrate that primary loss of function (LOF) gating properties accompanied by altered membrane characteristics may match effects of full haploinsufficiency on the neuronal level despite maintaining physiological peak current density, thereby causing DS. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
12. Regulation of motor pattern frequency by reversals in proprioceptive feedback
- Author
-
Smarandache, Carmen R., Daur, Nelly, Hedrich, Ulrike B. S., and Stein, Wolfgang
- Published
- 2008
13. Motor pattern selection by nitric oxide in the stomatogastric nervous system of the crab
- Author
-
Stein, Wolfgang, Eberle, Christina C., and Hedrich, Ulrike B. S.
- Published
- 2005
14. Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in KCNA1 -Associated Episodic Ataxia and a Comprehensive Review of the Literature.
- Author
-
Lauxmann, Stephan, Sonnenberg, Lukas, Koch, Nils A., Bosselmann, Christian, Winter, Natalie, Schwarz, Niklas, Wuttke, Thomas V., Hedrich, Ulrike B. S., Liu, Yuanyuan, Lerche, Holger, Benda, Jan, and Kegele, Josua
- Subjects
SODIUM channel blockers ,SPINOCEREBELLAR ataxia ,CHANNEL coding ,TREMOR ,DRUG repositioning ,ATAXIA - Abstract
Introduction: Among genetic paroxysmal movement disorders, variants in ion channel coding genes constitute a major subgroup. Loss-of-function (LOF) variants in KCNA1 , the gene coding for K
V 1.1 channels, are associated with episodic ataxia type 1 (EA1), characterized by seconds to minutes-lasting attacks including gait incoordination, limb ataxia, truncal instability, dysarthria, nystagmus, tremor, and occasionally seizures, but also persistent neuromuscular symptoms like myokymia or neuromyotonia. Standard treatment has not yet been developed, and different treatment efforts need to be systematically evaluated. Objective and Methods: Personalized therapeutic regimens tailored to disease-causing pathophysiological mechanisms may offer the specificity required to overcome limitations in therapy. Toward this aim, we (i) reviewed all available clinical reports on treatment response and functional consequences of KCNA1 variants causing EA1, (ii) examined the potential effects on neuronal excitability of all variants using a single compartment conductance-based model and set out to assess the potential of two sodium channel blockers (SCBs: carbamazepine and riluzole) to restore the identified underlying pathophysiological effects of KV 1.1 channels, and (iii) provide a comprehensive review of the literature considering all types of episodic ataxia. Results: Reviewing the treatment efforts of EA1 patients revealed moderate response to acetazolamide and exhibited the strength of SCBs, especially carbamazepine, in the treatment of EA1 patients. Biophysical dysfunction of KV 1.1 channels is typically based on depolarizing shifts of steady-state activation, leading to an LOF of KCNA1 variant channels. Our model predicts a lowered rheobase and an increase of the firing rate on a neuronal level. The estimated concentration dependent effects of carbamazepine and riluzole could partially restore the altered gating properties of dysfunctional variant channels. Conclusion: These data strengthen the potential of SCBs to contribute to functional compensation of dysfunctional KV 1.1 channels. We propose riluzole as a new drug repurposing candidate and highlight the role of personalized approaches to develop standard care for EA1 patients. These results could have implications for clinical practice in future and highlight the need for the development of individualized and targeted therapies for episodic ataxia and genetic paroxysmal disorders in general. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
15. 4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy.
- Author
-
Hedrich, Ulrike B. S., Lauxmann, Stephan, Wolff, Markus, Synofzik, Matthis, Bast, Thomas, Binelli, Adrian, Serratosa, José M., Martínez-Ulloa, Pedro, Allen, Nicholas M., King, Mary D., Gorman, Kathleen M., Zeev, Bruria Ben, Tzadok, Michal, Wong-Kisiel, Lily, Marjanovic, Dragan, Rubboli, Guido, Sisodiya, Sanjay M., Lutz, Florian, Ashraf, Harshad Pannikkaveettil, and Torge, Kirsten
- Subjects
POTASSIUM channels ,POTASSIUM antagonists ,PHYSICIANS ,SEIZURES (Medicine) ,GAIN-of-function mutations ,CEREBELLAR ataxia ,VAGUS nerve - Abstract
Targeting the K
+ ey current: Gain-of-function (GOF) mutations in the potassium channel Kv1.2 cause a subtype of developmental KCNA2-encephalopathy, characterized by the occurrence of seizures, cerebellar ataxia, and intellectual disabilities. The available treatments are mostly ineffective. Here, Hedrich et al. showed that the potassium channel blocker 4-aminopyridine (4-AP) corrected electrophysiological abnormalities in neurons in vitro. 4-AP was effective in reducing symptoms in 9 of 11 patients carrying GOF Kv1.2 mutations. Seizure reduction and improvements in movements and cognition were reported for the majority of the treated patients, without causing severe side effects. The results suggest that blocking potassium channels could be an effective approach for treating patients with GOF in Kv1.2. Developmental and epileptic encephalopathies are devastating disorders characterized by epilepsy, intellectual disability, and other neuropsychiatric symptoms, for which available treatments are largely ineffective. Following a precision medicine approach, we show for KCNA2-encephalopathy that the K+ channel blocker 4-aminopyridine can antagonize gain-of-function defects caused by variants in the KV 1.2 subunit in vitro, by reducing current amplitudes and negative shifts of steady-state activation and increasing the firing rate of transfected neurons. In n-of-1 trials carried out in nine different centers, 9 of 11 patients carrying such variants benefitted from treatment with 4-aminopyridine. All six patients experiencing daily absence, myoclonic, or atonic seizures became seizure-free (except some remaining provoked seizures). Two of six patients experiencing generalized tonic-clonic seizures showed marked improvement, three showed no effect, and one worsening. Nine patients showed improved gait, ataxia, alertness, cognition, or speech. 4-Aminopyridine was well tolerated up to 2.6 mg/kg per day. We suggest 4-aminopyridine as a promising tailored treatment in KCNA2-(gain-of-function)–encephalopathy and provide an online tool assisting physicians to select patients with gain-of-function mutations suited to this treatment. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
16. SCN2A channelopathies: Mechanisms and models.
- Author
-
Hedrich, Ulrike B. S., Lauxmann, Stephan, and Lerche, Holger
- Subjects
- *
SODIUM channels , *BRUGADA syndrome , *INTELLECTUAL disabilities , *FUNCTIONAL analysis , *SEIZURES (Medicine) , *PARTIAL epilepsy , *AUTISM - Abstract
Summary: Variants in the SCN2A gene, encoding the voltage‐gated sodium channel NaV1.2, cause a variety of neuropsychiatric syndromes with different severity ranging from self‐limiting epilepsies with early onset to developmental and epileptic encephalopathy with early or late onset and intellectual disability (ID), as well as ID or autism without seizures. Functional analysis of channel defects demonstrated a genotype‐phenotype correlation and suggested effective treatment options for one group of affected patients carrying gain‐of‐function variants. Here, we sum up the functional mechanisms underlying different phenotypes of patients with SCN2A channelopathies and present currently available models that can help in understanding SCN2A‐related disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. SCN2A channelopathies: Mechanisms and models.
- Author
-
Hedrich, Ulrike B. S., Lauxmann, Stephan, and Lerche, Holger
- Subjects
- *
SODIUM channels , *INTELLECTUAL disabilities , *FUNCTIONAL analysis , *SEIZURES (Medicine) , *BRUGADA syndrome , *AUTISM - Abstract
Summary: Variants in the SCN2A gene, encoding the voltage‐gated sodium channel NaV1.2, cause a variety of neuropsychiatric syndromes with different severity ranging from self‐limiting epilepsies with early onset to developmental and epileptic encephalopathy with early or late onset and intellectual disability (ID), as well as ID or autism without seizures. Functional analysis of channel defects demonstrated a genotype‐phenotype correlation and suggested effective treatment options for one group of affected patients carrying gain‐of‐function variants. Here, we sum up the functional mechanisms underlying different phenotypes of patients with SCN2A channelopathies and present currently available models that can help in understanding SCN2A‐related disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
18. Epileptogenese und Konsequenzen für die Therapie.
- Author
-
Hedrich, Ulrike B. S., Koch, Henner, Becker, Albert, and Lerche, Holger
- Abstract
Epilepsy is a frequent and disabling neurological disease with a significant burden for patients and their relatives worldwide. Epileptogenesis is understood as the plastic process that after an insult (in acquired epilepsies) finally leads to seizures with a latent period. In some cases, epileptogenesis has been clarified down to the molecular level. In parallel, the discovery of genetic defects has decisively contributed to unravel epileptic disease mechanisms. Both research directions have enabled first personalized treatment options. In addition, genetic variants associated with epilepsy can not only directly cause seizures but likely also induce an epileptogenic process (similar as in acquired epilepsies) and interact with developmental processes of the brain, finally leading to the typical age-dependent manifestation of genetic epilepsy syndromes. This article describes these correlations and the consequences for personalized treatment possibilities. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
19. KCNC1‐related disorders: new de novo variants expand the phenotypic spectrum.
- Author
-
Park, Joohyun, Koko, Mahmoud, Hedrich, Ulrike B. S., Hermann, Andreas, Cremer, Kirsten, Haberlandt, Edda, Grimmel, Mona, Alhaddad, Bader, Beck‐Woedl, Stefanie, Harrer, Merle, Karall, Daniela, Kingelhoefer, Lisa, Tzschach, Andreas, Matthies, Lars C., Strom, Tim M., Ringelstein, Erich Bernd, Sturm, Marc, Engels, Hartmut, Wolff, Markus, and Lerche, Holger
- Subjects
POTASSIUM channels ,INTELLECTUAL disabilities ,DISEASES ,DEVELOPMENTAL delay ,FUNCTIONAL analysis - Abstract
A recurrent de novo missense variant in KCNC1, encoding a voltage‐gated potassium channel expressed in inhibitory neurons, causes progressive myoclonus epilepsy and ataxia, and a nonsense variant is associated with intellectual disability. We identified three new de novo missense variants in KCNC1 in five unrelated individuals causing different phenotypes featuring either isolated nonprogressive myoclonus (p.Cys208Tyr), intellectual disability (p.Thr399Met), or epilepsy with myoclonic, absence and generalized tonic‐clonic seizures, ataxia, and developmental delay (p.Ala421Val, three patients). Functional analyses demonstrated no measurable currents for all identified variants and dominant‐negative effects for p.Thr399Met and p.Ala421Val predicting neuronal disinhibition as the underlying disease mechanism. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
20. Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies.
- Author
-
Masnada, Silvia, Hedrich, Ulrike B. S., Gardella, Elena, Schubert, Julian, Kaiwar, Charu, Klee, Eric W., Lanpher, Brendan C., Gavrilova, Ralitza H., Synofzik, Matthis, Bast, Thomas, Gorman, Kathleen, King, Mary D., Allen, Nicholas M., Conroy, Judith, Ben Zeev, Bruria, Tzadok, Michal, Korff, Christian, Dubois, Fanny, Ramsey, Keri, and Narayanan, Vinodh
- Subjects
- *
HEPATIC encephalopathy , *PHENOTYPES , *XENOPUS , *ELECTROENCEPHALOGRAPHY , *PARTIAL epilepsy , *ELECTROPHYSIOLOGY , *DIAGNOSIS of brain diseases , *DIAGNOSIS of epilepsy , *OVUM physiology , *BRAIN diseases , *ANIMALS , *EPILEPSY , *GENETIC techniques , *GENETIC mutation , *VERTEBRATES , *DISEASE complications - Abstract
Recently, de novo mutations in the gene KCNA2, causing either a dominant-negative loss-of-function or a gain-of-function of the voltage-gated K+ channel Kv1.2, were described to cause a new molecular entity within the epileptic encephalopathies. Here, we report a cohort of 23 patients (eight previously described) with epileptic encephalopathy carrying either novel or known KCNA2 mutations, with the aim to detail the clinical phenotype associated with each of them, to characterize the functional effects of the newly identified mutations, and to assess genotype-phenotype associations. We identified five novel and confirmed six known mutations, three of which recurred in three, five and seven patients, respectively. Ten mutations were missense and one was a truncation mutation; de novo occurrence could be shown in 20 patients. Functional studies using a Xenopus oocyte two-microelectrode voltage clamp system revealed mutations with only loss-of-function effects (mostly dominant-negative current amplitude reduction) in eight patients or only gain-of-function effects (hyperpolarizing shift of voltage-dependent activation, increased amplitude) in nine patients. In six patients, the gain-of-function was diminished by an additional loss-of-function (gain-and loss-of-function) due to a hyperpolarizing shift of voltage-dependent activation combined with either decreased amplitudes or an additional hyperpolarizing shift of the inactivation curve. These electrophysiological findings correlated with distinct phenotypic features. The main differences were (i) predominant focal (loss-of-function) versus generalized (gain-of-function) seizures and corresponding epileptic discharges with prominent sleep activation in most cases with loss-of-function mutations; (ii) more severe epilepsy, developmental problems and ataxia, and atrophy of the cerebellum or even the whole brain in about half of the patients with gain-of-function mutations; and (iii) most severe early-onset phenotypes, occasionally with neonatal onset epilepsy and developmental impairment, as well as generalized and focal seizures and EEG abnormalities for patients with gain- and loss-of-function mutations. Our study thus indicates well represented genotype-phenotype associations between three subgroups of patients with KCNA2 encephalopathy according to the electrophysiological features of the mutations. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
21. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
- Author
-
Wolff, Markus, Johannesen, Katrine M, Hedrich, Ulrike B S, Masnada, Silvia, Rubboli, Guido, Gardella, Elena, Lesca, Gaetan, Ville, Dorothée, Milh, Mathieu, Villard, Laurent, Afenjar, Alexandra, Chantot-Bastaraud, Sandra, Mignot, Cyril, Lardennois, Caroline, Nava, Caroline, Schwarz, Niklas, Gérard, Marion, Perrin, Laurence, Doummar, Diane, and Auvin, Stéphane
- Abstract
Mutations in SCN2A, a gene encoding the voltage-gated sodium channel Nav1.2, have been associated with a spectrum of epilepsies and neurodevelopmental disorders. Here, we report the phenotypes of 71 patients and review 130 previously reported patients. We found that (i) encephalopathies with infantile/childhood onset epilepsies (≥3 months of age) occur almost as often as those with an early infantile onset (<3 months), and are thus more frequent than previously reported; (ii) distinct phenotypes can be seen within the late onset group, including myoclonic-atonic epilepsy (two patients), Lennox-Gastaut not emerging from West syndrome (two patients), and focal epilepsies with an electrical status epilepticus during slow sleep-like EEG pattern (six patients); and (iii) West syndrome constitutes a common phenotype with a major recurring mutation (p.Arg853Gln: two new and four previously reported children). Other known phenotypes include Ohtahara syndrome, epilepsy of infancy with migrating focal seizures, and intellectual disability or autism without epilepsy. To assess the response to antiepileptic therapy, we retrospectively reviewed the treatment regimen and the course of the epilepsy in 66 patients for which well-documented medical information was available. We find that the use of sodium channel blockers was often associated with clinically relevant seizure reduction or seizure freedom in children with early infantile epilepsies (<3 months), whereas other antiepileptic drugs were less effective. In contrast, sodium channel blockers were rarely effective in epilepsies with later onset (≥3 months) and sometimes induced seizure worsening. Regarding the genetic findings, truncating mutations were exclusively seen in patients with late onset epilepsies and lack of response to sodium channel blockers. Functional characterization of four selected missense mutations using whole cell patch-clamping in tsA201 cells-together with data from the literature-suggest that mutations associated with early infantile epilepsy result in increased sodium channel activity with gain-of-function, characterized by slowing of fast inactivation, acceleration of its recovery or increased persistent sodium current. Further, a good response to sodium channel blockers clinically was found to be associated with a relatively small gain-of-function. In contrast, mutations in patients with late-onset forms and an insufficient response to sodium channel blockers were associated with loss-of-function effects, including a depolarizing shift of voltage-dependent activation or a hyperpolarizing shift of channel availability (steady-state inactivation). Our clinical and experimental data suggest a correlation between age at disease onset, response to sodium channel blockers and the functional properties of mutations in children with SCN2A-related epilepsy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
- Author
-
Syrbe, Steffen, Bertsche, Astrid, Bernhard, Matthias K, Merkenschlager, Andreas, Kiess, Wieland, Serratosa, José M, Nothnagel, Michael, May, Patrick, Krause, Roland, Dorn, Thomas, Vogt, Heinrich, Krämer, Günter, Mullis, Primus E, Linnankivi, Tarja, Lehesjoki, Anna-Elina, Sterbova, Katalin, Craiu, Dana C, Hoffman-Zacharska, Dorota, Hedrich, Ulrike B S, and Müller, Stephan
- Subjects
NEURONS ,EPILEPSY ,SPASMS ,PHENOTYPES ,POTASSIUM channels - Abstract
Epileptic encephalopathies are a phenotypically and genetically heterogeneous group of severe epilepsies accompanied by intellectual disability and other neurodevelopmental features. Using next-generation sequencing, we identified four different de novo mutations in KCNA2, encoding the potassium channel K
V 1.2, in six isolated patients with epileptic encephalopathy (one mutation recurred three times independently). Four individuals presented with febrile and multiple afebrile, often focal seizure types, multifocal epileptiform discharges strongly activated by sleep, mild to moderate intellectual disability, delayed speech development and sometimes ataxia. Functional studies of the two mutations associated with this phenotype showed almost complete loss of function with a dominant-negative effect. Two further individuals presented with a different and more severe epileptic encephalopathy phenotype. They carried mutations inducing a drastic gain-of-function effect leading to permanently open channels. These results establish KCNA2 as a new gene involved in human neurodevelopmental disorders through two different mechanisms, predicting either hyperexcitability or electrical silencing of KV 1.2-expressing neurons. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
23. Impaired Action Potential Initiation in GAB Aergic Interneurons Causes Hyperexcitable Networks in an Epileptic Mouse Model Carrying a Human NaV1.1 Mutation.
- Author
-
Hedrich, Ulrike B. S., Liautard, Camille, Kirschenbaum, Daniel, Pofahl, Martin, Lavigne, Jennifer, Yuanyuan Liu, Theiss, Stephan, Slotta, Johannes, Escayg, Andrew, Dihné, Marcel, Beck, Heinz, Mantegazza, Massimo, and Lerche, Holger
- Subjects
- *
ACTION potentials , *GABA agents , *INTERNEURONS , *PEOPLE with epilepsy , *GENETIC mutation , *SODIUM ions , *LABORATORY mice - Abstract
Mutations in SCN1A and other ion channel genes can cause different epileptic phenotypes, but the precise mechanisms underlying the development of hyperexcitable networks are largely unknown. Here, we present a multisystem analysis of an SCN1A mouse model carrying the Nav1.1-R1648H mutation, which causes febrile seizures and epilepsy in humans. We found a ubiquitous hypoexcitability of interneurons in thalamus, cortex, and hippocampus, without detectable changes in excitatory neurons. Interestingly, somatic Na+ channels in interneurons and persistent Na+ currents were not significantly changed. Instead, the key mechanism of interneuron dysfunction was a deficit of action potential initiation at the axon initial segment that was identified by analyzing action potential firing. This deficit increased with the duration of firing periods, suggesting that increased slow inactivation, as recorded for recombinant mutated channels, could play an important role. The deficit in interneuron firing caused reduced action potential-driven inhibition of excitatory neurons as revealed by less frequent spontaneous but not miniature IPSCs. Multiple approaches indicated increased spontaneous thalamocortical and hippocampal network activity in mutant mice, as follows: (1) more synchronous and higher-frequency firing was recorded in primary neuronal cultures plated on multielectrode arrays; (2) thalamocortical slices examined by field potential recordings revealed spontaneous activities and pathological high-frequency oscillations; and (3) multineuron Ca2+ imaging in hippocampal slices showed increased spontaneous neuronal activity. Thus, an interneuron-specific generalized defect in action potential initiation causes multisystem disinhibition and network hyperexcitability, which can well explain the occurrence of seizures in the studied mouse model and in patients carrying this mutation. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
24. An SCN2A mutation in a family with infantile seizures from Madagascar reveals an increased subthreshold Na+ current.
- Author
-
Lauxmann, Stephan, Boutry‐Kryza, Nadia, Rivier, Clotilde, Mueller, Stephan, Hedrich, Ulrike B. S., Maljevic, Snezana, Szepetowski, Pierre, Lerche, Holger, and Lesca, Gaetan
- Subjects
EPILEPSY research ,ION channels ,SODIUM channels ,ELECTROENCEPHALOGRAPHY ,SPASMS ,MISSENSE mutation - Abstract
Missense mutations in SCN2A, encoding the brain sodium channel Na
V 1.2, have been described in benign familial neonatal-infantile seizures ( BFNIS), a self-limiting disorder, whereas several SCN2A de novo nonsense mutations have been found in patients with more severe phenotypes including epileptic encephalopathy. We report a family with BFNIS originating from Madagascar. Onset extended from 3 to 9 months of age. Interictal EEGs were normal. In two patients, ictal electroencephalography ( EEG) studies showed partial seizure patterns with secondary generalization in one. Seizures remitted before 18 months of age, with or without medication. Intellectual development was normal. A novel missense mutation of SCN2A, c.4766A>G/p.Tyr1589Cys, was found in a highly conserved region of NaV 1.2 (D4/S2-S3). Functional studies using heterologous expression in tsA201 cells and whole-cell patch clamping revealed a depolarizing shift of steady-state inactivation, increased persistent Na+ current, a slowing of fast inactivation and an acceleration of its recovery, thus a gain-of-function. Using an action potential waveform in a voltage-clamp experiment we indicated an increased inward Na+ current at subthreshold voltages, which can explain a neuronal hyperexcitability. Our results suggest that this mutation induces neuronal hyperexcitability, resulting in infantile epilepsy with favorable outcome. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
25. Characterization of a descending pathway: activation and effects on motor patterns in the brachyuran crustacean stomatogastric nervous system.
- Author
-
Hedrich, Ulrike B. S. and Stein, Wolfgang
- Subjects
- *
MOTOR ability , *CENTRAL nervous system , *NEURAL stimulation , *CRABS , *INGESTION , *METABOLISM - Abstract
The regulation of motor patterns by higher-order neuronal centers ensures appropriate motor function and behavior, but only a few studies have characterized this regulation at the cellular level. Here, we address motor pattern regulation in the stomatogastric nervous system (STNS) of the crab Cancer pagurus. This easily accessible model system is an extension of the central nervous system and contains the motor circuits that generate the rhythmic motor patterns for ingestion (esophageal rhythm) and processing of food (gastric mill and pyloric rhythms). We have documented the actions of two identified neurons located in the brain on the STNS motor circuits. We show that these neurons provide exteroceptive chemosensory information to the motor circuits and we outline their axonal projection patterns, their firing activity and their effects on three motor patterns. Backfill stainings and activity measurements in vivo and in vitro show that two neurons located in cluster 17 of the brain project via the inferior ventricular (IV) nerve to the STNS. These IV neurons started to burst rhythmically when chemosensory stimuli were applied to the first antennae. When rhythmically activated in vitro, gastric mill rhythms were elicited or, if already active, entrained by the IV neuron activity. In addition, IV neuron stimulation excited the esophageal motor neuron and inhibited several pyloric neurons such that the timing of the IV neuron activity was imposed on all motor rhythms. The IV neurons were thus capable of synchronizing the activities of different motor circuits, which demonstrates the regulation of motor patterns by higher-order neuronal centers. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
26. Functional consequences of activity-dependent synaptic enhancement at a crustacean neuromuscular junction.
- Author
-
Stein, Wolfgang, Smarandache, Carmen R., Nickmann, Melanie, and Hedrich, Ulrike B. S.
- Subjects
NEUROMUSCULAR transmission ,MYONEURAL junction ,STOMACH physiology ,MUSCLES ,NEUROMUSCULAR system ,CRUSTACEA - Abstract
This study provides evidence that activity-dependent synaptic enhancement at a neuromuscular junction modifies the characteristics of force production of the receiving muscle during rhythmic motor neuron discharge patterns. Long-lasting augmentation of the excitatory junction potentials (EJPs) quickens and strengthens the muscle response to a given motor pattern. We used the muscle gm6 of the crab Cancer pagurus to study the functional consequences and temporal dynamics of facilitation and augmentation. This stomach muscle is driven by the rhythmic activity of the gastric mill central pattern generator in the stomatogastric nervous system. We tested the response of this muscle to rhythmic motor drive using a variety of gastric mill-like stimulations. EJPs recorded in muscle gm6 were initially small but are summated and facilitated strongly with continuous stimulation. Facilitation increased with shorter interspike intervals and possessed a time constant of decay <1 s. During gastric mill rhythms, motor neuron activity was by contrast represented by bursts of activity with intermittent pauses of several seconds. Recordings in intact animals and in the isolated nervous system showed a great variability in firing frequency and temporal distribution of motor neuron bursts. Train stimulations with various stimulus frequencies (5 Hz, 10 Hz, 20 Hz) and inter-train intervals (2 s, 4 s, 8 s, 16 s, 32 s) revealed that augmentation acted in addition to facilitation. Augmentation increased muscle EJPs during stimulations with inter-train intervals of 16 s or less. The effects of augmentation increased with shorter inter-train intervals, but were independent of stimulus frequency. Augmentation also contributed to the electrical response of the muscle during gastric mill rhythms, which were obtained in vitro and in vivo, and was also reflected by an increase of muscle force and the slope of force development during repetitive train stimulation. We conclude that the augmentation of EJPs at the neuromuscular junction tunes the muscle response to support force production during rhythmic motor patterns. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
27. Early-onset familial hemiplegic migraine due to a novel SCN1A mutation.
- Author
-
Fan, Chunxiang, Wolking, Stefan, Lehmann-Horn, Frank, Hedrich, Ulrike B. S., Freilinger, Tobias, Lerche, Holger, Borck, Guntram, Kubisch, Christian, Jurkat-Rott, Karin, and Hedrich, Ulrike Bs
- Subjects
- *
MIGRAINE , *GENETIC mutation , *GENETIC testing , *INTERNEURONS , *ELECTROPHYSIOLOGY , *GENETICS , *MIGRAINE diagnosis , *DISEASE susceptibility , *GENEALOGY , *GENETIC polymorphisms , *GENETIC techniques , *GENETIC markers , *MEMBRANE transport proteins - Abstract
Introduction Familial hemiplegic migraine (FHM) is a rare autosomal dominant subtype of migraine with aura. The FHM3 subtype is caused by mutations in SCN1A, which is also the most frequent epilepsy gene encoding the voltage-gated Na+ channel NaV1.1. The aim of this study was to explore the clinical, genetic and pathogenetic features of a pure FHM3 family. Methods A three-generation family was enrolled in this study for genetic testing and assessment of clinical features. Whole cell patch-clamp was performed to determine the functions of identified mutant NaV1.1 channels, which were transiently expressed in human tsA201 cells together with β1 and β2 subunits. Results and conclusions We identified a novel SCN1A (p.Leu1624Pro) mutation in a pure FHM family with notably early-onset attacks at mean age of 7. L1624P locates in S3 of domain IV, the same domain as two of four known pure FHM3 mutations. Compared to WT channels, L1624P displayed an increased threshold-near persistent current in addition to other gain-of-function features such as: a slowing of fast inactivation, a positive shift in steady-state inactivation, a faster recovery and higher channel availability during repetitive stimulation. Similar to the known FHM3 mutations, this novel mutation predicts hyperexcitability of GABAergic inhibitory neurons. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.